Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Risk-guided Disease Management and Tele-rehabilitation Program to Reduce Re-admissions in Coronary Artery Disease (Risk-Guided CAD)

NCT04966117 is registered in ClinicalTrials.gov with Baker Heart and Diabetes Institute as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04966117 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Risk-guided Disease Management and Tele-rehabilitation Program to Reduce Re-admissions in Coronary Artery Disease (Risk-Guided CAD)
Lead sponsor
Baker Heart and Diabetes Institute
Phase
Not applicable
Overall status
Completed
Start date
July 17, 2021
Completion date
July 10, 2025
Enrollment
101 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.